A patient-centered lupus drug development meeting, “Lupus: Patient Voices”, will be held in spring 2017. The Alliance for Lupus Research (ALR), the Lupus and Allied Diseases Association (LADA), Lupus Foundation of America (LFA), and the Lupus Research Institute (LRI) will organize the event that will focus on patient viewpoints, daily impacts…
Interferon gamma could be a key trigger for lupus, a finding that may provide information leading to new treatments for the autoimmune disease, according to researchers at Penn State College of Medicine. The study, “IFN-γ receptor and STAT1 signaling in B cells are central to spontaneous germinal…
Resolve Therapeutics, a biopharma developing innovative therapies for Systemic Lupus Erythematosus (SLE) and Sjogrens syndrome, will present new data from two clinical studies at the EULAR Annual European Congress of Rheumatology, June 8-11, in London. The company’s scientific founder Dr. Keith Elkon will deliver the oral presentation “Immune Complex Bound…
Sanford Burnham Prebys Medical Discovery Research Institute researchers have uncovered a new protein called P-selectin glycoprotein ligand-1 (PSGL-1) that is involved in the regulation of T-cell immune responses, with implications in autoimmune diseases. The findings have recently been published in Immunity in a study titled “…
Various ethnic groups differ in what specific symptoms of systemic lupus erythematosus (SLE) they display — a difference that might be linked to the presence of different immune factors, according to a new study. Understanding how ethnicity might influence these differences can pave the way for treatments that are better…
Treatment of systemic lupus erythematosus (SLE) needs to reflect the involvement of particular organs as well as the severity of disease, according to a study presented at the Congress of Clinical Rheumatology Annual Meeting, scrutinizing published clinical trials of lupus. The study advocated giving more weight to clinical experience…
The Alliance for Lupus Research (ALR) partnered with Willie Colon, the former New York Jets offensive guard, for the second Annual Willie Colon Charity Golf Outing fundraiser benefitting the ALR Jean Davis Research Grant. Money raised at the event is used to further ALR-targeted research efforts. Other former National Football League players who attended…
Bridget Hood, a Lupus L.A. board member who lives with the disease, has published an editorial in a California newspaper to mark May —  Lupus Awareness Month — and to raise awareness of lupus and advocate for new research into potential treatments or a cure. Specifically, Hood called on policymakers to do…
The Defense Appropriations Committee of the U.S. House of Representatives passed a bill allocating $5 million in new funding for a peer-reviewed Lupus Medical Research Program on May 17. The program, included in a 2017 Defense Appropriations spending bill, is to be operated by the U.S. Defense Department. A…
Researchers have identified an enzyme called SHP-2 whose levels are significantly increased in blood samples of lupus patients and in systemic lupus erythematosus (SLE) mouse models, which can become a potential therapeutic target for patients suffering from this disease. The study, “Inhibition of SHP2 ameliorates the pathogenesis of systemic lupus…